Online citations, reference lists, and bibliographies.
← Back to Search

Endogenous Polymers As Biomaterials For Nanoparticulate Gene Therapy

G. K. Zorzi, B. Seijo, B. Seijo, A. Sánchez, A. Sánchez
Published 2015 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1038/sj.gt.3301089
Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes
S. Kawakami (2000)
10.1016/j.jconrel.2013.09.019
Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
Ahmed O Elzoghby (2013)
10.1248/BPB.22.836
Receptor-mediated gene transfer to cells of hepatic origin by galactosylated albumin-polylysine complexes.
J. Han (1999)
10.1186/1556-276X-6-532
Effect of introduction of chondroitin sulfate into polymer-peptide conjugate responding to intracellular signals
Tetsuro Tomiyama (2011)
10.4049/jimmunol.181.5.2990
Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity1
C. Bourquin (2008)
10.1007/s11095-008-9745-6
Investigating the Movement of Intravitreal Human Serum Albumin Nanoparticles in the Vitreous and Retina
Hyuncheol Kim (2008)
10.1002/bip.21327
Elastin‐like polypeptides: Biomedical applications of tunable biopolymers
Sarah R MacEwan (2010)
10.1007/s11671-010-9750-7
Persistent deNOx Ability of CaAl2O4:(Eu, Nd)/TiO2-xNy Luminescent Photocatalyst
H. Li (2010)
10.2217/nnm.12.51
Exploring the efficiency of gallic acid-based dendrimers and their block copolymers with PEG as gene carriers.
M. de la Fuente (2012)
10.1007/s11095-007-9410-5
Delivery by Cationic Gelatin Nanoparticles Strongly Increases the Immunostimulatory Effects of CpG Oligonucleotides
Klaus Zwiorek (2007)
10.1002/JPS.20616
Effect of cationized gelatins on the paracellular transport of drugs through caco-2 cell monolayers.
T. Seki (2006)
10.1002/smll.201301992
Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.
Jianfeng Han (2014)
10.1021/mp200155t
Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles.
Giovanni Konat Zorzi (2011)
10.1248/CPB.53.871
Lipid carrier systems for targeted drug and gene delivery.
M. Hashida (2005)
10.1021/BI00890A017
THE STRUCTURE AND CHEMISTRY OF COLOMINIC ACID.
E. J. Mcguire (1964)
10.1002/jgm.2694
In vivo gene transfer using pDNA/chitosan/chondroitin sulfate ternary complexes: influence of chondroitin sulfate on the stability of freeze‐dried complexes and transgene expression in vivo
Kenji Hagiwara (2013)
10.1016/J.ADDR.2006.03.007
Current status of polymeric gene delivery systems.
T. Park (2006)
10.1167/IOVS.05-0165
Vitreous: a barrier to nonviral ocular gene therapy.
L. Peeters (2005)
10.1021/jm100509v
Folate-targeted therapies for cancer.
W. Xia (2010)
10.1016/S0142-9612(97)00103-8
Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization.
J. Grzesiak (1997)
10.1093/NAR/GNH093
Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.
Y. Minakuchi (2004)
10.1021/bm800276d
Why is chitosan mucoadhesive?
Ioannis A Sogias (2008)
10.5860/choice.45-5590
Carbohydrate Chemistry and Biochemistry: Structure and Mechanism
M. Sinnott (2007)
10.1016/j.biomaterials.2009.04.041
The development of a gene vector electrostatically assembled with a polysaccharide capsule.
T. Kurosaki (2009)
10.1038/gt.2008.16
Bioadhesive hyaluronan–chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue
M. Fuente (2008)
Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells
Laura Contreras-Ruiz (2011)
10.1007/978-4-431-77924-7_21
Structural Analysis of Polysialic Acid
C. Sato (2008)
10.1016/J.ADDR.2007.03.005
RNAi therapeutics: principles, prospects and challenges.
L. Aagaard (2007)
10.2174/157340611795564277
Chemically modified gelatin as biomaterial in the design of new nanomedicines.
R. López-Cebral (2011)
10.1021/nn1005599
Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine.
M. Gou (2010)
10.1023/A:1016486910719
Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery
Goldie Kaul (2004)
10.1016/j.biomaterials.2013.06.066
Albumin-based nanoconjugates for targeted delivery of therapeutic oligonucleotides.
X. Ming (2013)
10.1080/03639040802026012
Polymers for Mucoadhesive Drug Delivery System: A Current Status
G. S. Asane (2008)
10.1093/GLYCOB/CWG005
A novel GlcNAcα1-HPO3-6Gal(1-1)ceramide antigen and alkylated inositol-phosphoglycerolipids expressed by the liver fluke Fasciola hepatica
M. Wuhrer (2003)
10.1016/S1386-1425(00)00313-9
Spectroscopic studies on the interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants.
E. L. Gelamo (2000)
10.1080/10611860802475639
Synthesis of folate-conjugated amphiphiles for tumor-targeted drug delivery
Shiladitya Bhattacharya (2008)
10.1002/mabi.201100005
Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy.
G. K. Zorzi (2011)
10.1016/0142-9612(96)85911-4
Characterization of a hyaluronic acid-Arg-Gly-Asp peptide cell attachment matrix.
J. Glass (1996)
10.1016/S0142-9612(03)00343-0
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond.
U. Hersel (2003)
10.1016/B978-008045382-8.00698-5
Collagen Formation and Structure
H. Bächinger (2010)
10.1021/bc700421u
Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
Yanli Liu (2008)
10.1016/j.pnmrs.2014.01.002
Progress in the characterization of bio-functionalized nanoparticles using NMR methods and their applications as MRI contrast agents.
R. López-Cebral (2014)
10.1016/j.nano.2012.03.008
Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer.
L. Piao (2013)
10.1016/S0168-3659(03)00197-4
In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents.
T. Kushibiki (2003)
10.1016/J.JCONREL.2006.02.003
Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds.
T. Kushibiki (2006)
10.1016/J.EJPB.2004.07.014
Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect.
J. Weyermann (2005)
10.1016/S0142-9612(02)00445-3
In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.
D. Fischer (2003)
10.18433/J3GK52
Chondroitin sulfate capsule system for efficient and secure gene delivery.
T. Kurosaki (2010)
10.1080/10611860802438710
Delivery of interleukin-18 gene to lung cancer cells using cationic emulsion
Hyun-Suk Kang (2009)
Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene
Y. Mo (2007)
10.1016/J.JCONREL.2005.02.030
Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis.
T. Kushibiki (2005)
10.1016/j.ejpb.2008.04.026
Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles.
J. Zillies (2008)
10.1679/AOHC.55.503
Localization of hyaluronic acid, chondroitin sulfate, and CD44 in rabbit cornea.
A. Asari (1992)
10.1248/YAKUSHI.130.917
Development of non-viral vector for cancer gene therapy.
Y. Hattori (2010)
10.1016/B978-0-12-374396-1.00081-7
Chemistry and Materials Development of Protein-Based Nanoparticles
Jianhua Rong (2011)
10.1016/j.colsurfb.2009.04.026
Synthesis and characterization of stearyl protamine and investigation of their complexes with DNA for gene delivery.
J. Liu (2009)
10.1038/sj.cgt.7701118
New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
K. Yamato (2008)
10.1016/j.colsurfb.2013.12.022
Application of NMR spectroscopy in the development of a biomimetic approach for hydrophobic drug association with physical hydrogels.
R. López-Cebral (2014)
10.1016/j.jconrel.2009.04.021
Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery.
Jie Shen (2009)
10.1038/nrd2742
Knocking down barriers: advances in siRNA delivery
K. Whitehead (2009)
10.2147/IJN.S32363
Ultrasound-targeted transfection of tissue-type plasminogen activator gene carried by albumin nanoparticles to dog myocardium to prevent thrombosis after heart mechanical valve replacement
J. Ji (2012)
10.3390/ijms14011629
Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering
Sachiko Nitta (2013)
10.1074/jbc.M307201200
Characterization of the Recombinant Rat 175-kDa Hyaluronan Receptor for Endocytosis (HARE)*
J. A. Weigel (2003)
10.1016/S0006-291X(02)00558-2
The hyaluronan receptor for endocytosis (HARE) is not CD44 or CD54 (ICAM-1).
J. A. Weigel (2002)
10.1111/j.1349-7006.2006.00174.x
Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma
G. Matsumoto (2006)
10.1016/j.jconrel.2012.04.036
Protein-based nanocarriers as promising drug and gene delivery systems.
Ahmed O Elzoghby (2012)
10.1016/J.ADDR.2004.10.001
Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.
M. Friede (2005)
10.1016/j.ijpharm.2010.12.023
Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
K. Ulbrich (2011)
10.1021/JS950474+
Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.
P. Calvo (1996)
10.1093/INTIMM/11.3.393
Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin.
H. Kawashima (1999)
10.1016/j.visres.2007.07.012
Nanoparticle applications in ocular gene therapy
Xue Cai (2008)
10.1016/j.biomaterials.2009.11.001
The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine.
Young-Suk Choi (2010)
10.1016/B978-0-444-53349-4.00247-8
9.03 – Collagen
W. Wagermaier (2012)
10.1016/B978-0-12-803581-8.10190-0
4.25 Drug Delivery via Heparin Conjugates
S. Sakiyama-Elbert (2017)
10.2147/IJN.S34288
Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
C. M. Kummitha (2012)
10.2147/IJN.S23582
Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A
L. Zhang (2011)
10.1016/J.JCONREL.2004.02.020
Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.
N. Dinauer (2004)
10.1163/156856200743508
Modification of the adhesive properties of collagen by covalent grafting with RGD peptides
J. L. Myles (2000)
10.1080/02713680590934148
Chondroitin Sulfate Proteoglycans Are Structural Renewable Constituents of the Rabbit Vitreous Body
R. Góes (2005)
Extracellular matrix, supramolecular organisation and shape.
J. Scott (1995)
10.4052/TIGG.12.283
Interaction of Chondroitin Sulfate Proteoglycans with Selectins, CD44, and Chemokines
H. Kawashima (2000)
10.1016/B978-0-08-055294-1.00136-7
Drug Delivery via Heparin Conjugates
S. Sakiyama-Elbert (2011)
10.1016/J.JCONREL.2003.10.009
Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide.
A. Arnedo (2004)
10.2174/138955710791185127
Polycationic nanoparticles as nonviral vectors employed for gene therapy in vivo.
J. Xing (2010)
10.1016/J.JCONREL.2005.04.019
Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.
G. Mayer (2005)
10.1023/A:1015396825274
Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin
Victor Tuan Giam Chuang (2004)
10.1016/J.JCONREL.2006.11.020
Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier.
I. Kratzer (2007)
10.1016/S0142-9612(03)00339-9
Biomimetic materials for tissue engineering.
H. Shin (2003)
10.1016/J.IJPHARM.2005.06.007
Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids.
G. Gregoriadis (2005)
10.1021/JS970367A
Analysis of plasmid DNA from a pharmaceutical perspective.
C. R. Middaugh (1998)
10.1016/J.AJPS.2014.03.001
Application of sialic acid/polysialic acid in the drug delivery systems
T. Zhang (2014)
10.1007/s11095-010-0149-z
Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages
Wangyang Yu (2010)
10.1248/BPB.B12-00728
Ocular gene delivery systems using ternary complexes of plasmid DNA, polyethylenimine, and anionic polymers.
T. Kurosaki (2013)
10.1016/J.EJPB.2004.04.001
Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization.
D. Lochmann (2005)
10.1023/A:1016015803611
Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A
P. Calvo (2004)
10.3109/10611869908996842
Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands.
K. Ogawara (1999)
10.1088/0957-4484/19/7/075105
Design of novel polysaccharidic nanostructures for gene delivery.
M. de la Fuente (2008)
10.1038/gt.2012.56
A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model
L. Contreras-Ruiz (2013)
10.1038/ncb1975
Induction of autophagy by spermidine promotes longevity
T. Eisenberg (2009)
10.1167/iovs.07-1077
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
[Hyaluronan: structure, metabolism, functions, and role in wound healing].
Paweł Olczyk (2008)
10.1074/jbc.M709921200
The Hyaluronan Receptor for Endocytosis Mediates Hyaluronan-dependent Signal Transduction via Extracellular Signal-regulated Kinases*
S. Kyosseva (2008)
10.1016/j.addr.2009.04.001
Delivery of RNA interference therapeutics using polycation-based nanoparticles.
K. Howard (2009)
10.1093/glycob/cwn045
The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
E. N. Harris (2008)
10.1007/S003960050050
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
10.1016/J.IJPHARM.2007.02.004
Effects of a sperminated gelatin on the nasal absorption of insulin.
T. Seki (2007)
10.1016/J.JCONREL.2004.11.029
Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution.
V. Vogel (2005)
10.1016/J.ADDR.2006.03.001
Natural polymers for gene delivery and tissue engineering.
Jiyoung M Dang (2006)
10.1016/J.IJPHARM.2004.08.015
Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells.
L. Zhang (2004)
10.1074/JBC.M405322200
Endocytic Function, Glycosaminoglycan Specificity, and Antibody Sensitivity of the Recombinant Human 190-kDa Hyaluronan Receptor for Endocytosis (HARE)*
E. N. Harris (2004)
10.1016/B978-0-444-53349-4.00246-6
9.08 – Polysaccharides
E.-H. Song (2012)
10.1111/j.1445-5994.2005.00908.x
Mannose‐binding lectin: biology and clinical implications
D. Worthley (2005)
10.1248/BPB.28.2007
Targeting of plasmid DNA to renal interstitial fibroblasts by cationized gelatin.
T. Kushibiki (2005)
10.1007/s00726-007-0513-4
Spermine and spermidine mediate protection against oxidative damage caused by hydrogen peroxide
J. E. Rider (2007)
10.1016/j.jconrel.2008.05.010
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
10.1158/1535-7163.MCT-08-0473
Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
E. Kawata (2008)
10.1023/A:1016281324761
Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress and Prospects
R. Stull (2004)
10.1016/0014-5793(93)81177-2
Polysialic acids: potential in drug delivery
G. Gregoriadis (1993)
10.1016/j.carbpol.2013.11.024
Pullulan-protamine as efficient haemocompatible gene delivery vector: synthesis and in vitro characterization.
S. Priya (2014)
10.1038/nature01451
Regulated portals of entry into the cell
S. Conner (2003)
10.1016/J.EJPB.2004.03.018
Biomimetic polymers in pharmaceutical and biomedical sciences.
S. Drotleff (2004)
10.1016/j.biomaterials.2012.06.040
The effects of coating pDNA/chitosan complexes with chondroitin sulfate on physicochemical characteristics and cell transfection.
Kenji Hagiwara (2012)
10.1016/J.JCONREL.2005.11.007
Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds.
T. Kushibiki (2006)
10.1038/sj.gt.3302285
Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin
T. Kushibiki (2004)
10.1163/156856206777346278
In vitro transfection of plasmid DNA by cationized gelatin prepared from different amine compounds
T. Kushibiki (2006)
10.1016/J.NANO.2006.11.008
The present and future of nanotechnology in human health care.
S. Sahoo (2007)
10.1073/PNAS.0501753102
Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.
F. Takeshita (2005)
10.1016/j.cbi.2013.04.007
Biological effects induced by BSA-stabilized silica nanoparticles in mammalian cell lines.
Rasmus Foldbjerg (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar